![Mark A. Kay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark A. Kay
Direktor/Vorstandsmitglied bei Genevant Sciences Corp.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jonathan Quick | M | - | 5 Jahre | |
Frédéric Chéreau | M | 57 | 8 Jahre | |
Bo Rode Hansen | M | - |
Genevant Sciences Corp.
![]() Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | - |
Michael Snyder | M | - |
Stanford University School of Medicine
| 15 Jahre |
Marie Payton | F | - | 5 Jahre | |
Bruno C. Medeiros | M | - |
Stanford University School of Medicine
| - |
William Collier | M | 64 |
Genevant Sciences Corp.
![]() Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | - |
John W. Day | M | - |
Stanford University School of Medicine
| 13 Jahre |
Matthias Hebben | M | - | 5 Jahre | |
Vikram Bajaj | M | 46 |
Stanford University School of Medicine
| 10 Jahre |
Oliver Dorigo | M | - |
Stanford University School of Medicine
| - |
Simon Stertzer | M | 88 |
Stanford University School of Medicine
| 26 Jahre |
Philip Hanno | M | - |
Stanford University School of Medicine
| 8 Jahre |
Calvin J. Kuo | M | - |
Stanford University School of Medicine
| - |
Walter Greenleaf | M | - |
Stanford University School of Medicine
| 7 Jahre |
George W. Sledge | M | 73 |
Stanford University School of Medicine
| - |
Alejandro Dorenbaum | M | 64 |
Stanford University School of Medicine
| - |
Michael Franken | M | 59 | 3 Jahre | |
Sandra Horning | M | 75 |
Stanford University School of Medicine
| - |
Joseph Wolk | M | 57 |
Stanford University School of Medicine
| - |
Ryan Spitler | M | - |
Stanford University School of Medicine
| 8 Jahre |
Stefan Heller | M | 58 |
Stanford University School of Medicine
| - |
Theodore Tussing | M | - |
Stanford University School of Medicine
| - |
Janice Olson | F | - | 3 Jahre | |
Hannah Valantine | M | 72 |
Stanford University School of Medicine
| 37 Jahre |
Kiki Chang | M | - |
Stanford University School of Medicine
| - |
Henry Greely | M | - |
Stanford University School of Medicine
| - |
Gary Berke | M | - |
Stanford University School of Medicine
| - |
Susan Hoerger | F | - |
Stanford University School of Medicine
| - |
Phil Yang | M | - |
Stanford University School of Medicine
| - |
Judith Ned | F | - |
Stanford University School of Medicine
| - |
Christi Opitz | F | - |
Stanford University School of Medicine
| - |
Chris Zeise | M | - |
Stanford University School of Medicine
| - |
Jennifer Rosingana | F | - |
Stanford University School of Medicine
| - |
Grace Lochhead | F | - | 3 Jahre | |
Mintu Turakhia | M | 50 |
Stanford University School of Medicine
| 16 Jahre |
Glenn Matthew Chertow | M | - |
Stanford University School of Medicine
| - |
Stephen Galli | M | 77 |
Stanford University School of Medicine
| 25 Jahre |
Sachie Oshima | M | 52 |
Stanford University School of Medicine
| 17 Jahre |
Eugene Bauer | M | 81 |
Stanford University School of Medicine
| 36 Jahre |
Emmett Cunningham | M | 63 |
Stanford University School of Medicine
| 16 Jahre |
Mark J. Murray | M | 75 |
Genevant Sciences Corp.
![]() Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | - |
Peter A. Zorn | M | 53 |
Genevant Sciences Corp.
![]() Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | 5 Jahre |
David Karpf | M | 69 |
Stanford University School of Medicine
| - |
Joseph Wu | M | - |
Stanford University School of Medicine
| 11 Jahre |
George Tidmarsh | M | 64 |
Stanford University School of Medicine
| 14 Jahre |
Ramon Chavez Márquez | M | 60 |
Stanford University School of Medicine
| 9 Jahre |
Michelle Brandt | F | - |
Stanford University School of Medicine
| - |
Lucy Shapiro | M | 83 |
Stanford University School of Medicine
| 35 Jahre |
Peter Fitzgerald | M | 66 |
Stanford University School of Medicine
| 27 Jahre |
Lawrence Steinman | M | 76 |
Stanford University School of Medicine
| - |
Edgar Engleman | M | 78 |
Stanford University School of Medicine
| 34 Jahre |
Paul A. Berg | M | 97 |
Stanford University School of Medicine
| - |
Steven J. Chu | M | 76 |
Stanford University School of Medicine
| 11 Jahre |
Peter Kim | M | 65 |
Stanford University School of Medicine
| 10 Jahre |
Christopher Viehbacher | M | 64 |
Stanford University School of Medicine
| - |
Daria Mochly-Rosen | M | - |
Stanford University School of Medicine
| - |
William J. Maloney | M | - |
Stanford University School of Medicine
| 20 Jahre |
Emmet B. Keeffe | M | - |
Stanford University School of Medicine
| - |
Thomas C. Südhof | M | 68 |
Stanford University School of Medicine
| - |
Eddie C. Cheung | M | - |
Stanford University School of Medicine
| - |
Jeffrey Glenn | M | 61 |
Stanford University School of Medicine
| 24 Jahre |
K. Christopher Garcia | M | - |
Stanford University School of Medicine
| 25 Jahre |
Jillian Manus | F | - |
Stanford University School of Medicine
| 6 Jahre |
Paul Blumenthal | M | - |
Stanford University School of Medicine
| - |
Thomas Krummel | M | 72 |
Stanford University School of Medicine
| - |
James Newman | M | - |
Stanford University School of Medicine
| - |
Roger Kornberg | M | 76 |
Stanford University School of Medicine
| 46 Jahre |
Frank Torti | M | 45 |
Genevant Sciences Corp.
![]() Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | - |
Amato Giaccia | M | 65 |
Stanford University School of Medicine
| - |
Thomas Raffin | M | 77 |
Stanford University School of Medicine
| - |
Lawrence M. Shuer | M | - |
Stanford University School of Medicine
| - |
Terrence Blaschke | M | 81 |
Stanford University School of Medicine
| 50 Jahre |
Garry Nolan | M | 63 |
Stanford University School of Medicine
| - |
James Gillespie | M | - |
Stanford University School of Medicine
| 7 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Cecilia Jones | F | 49 | 1 Jahre | |
Richard A. Moscicki | M | 72 | 4 Jahre | |
Farzad Soleimani | M | - |
Stanford University School of Medicine
| 5 Jahre |
Bryan Yoon | M | 46 | 1 Jahre | |
Leszek Lisowski | M | - | - | |
Michael Wyzga | M | 69 | 4 Jahre | |
Susan R. Kahn | F | 67 | 1 Jahre | |
Andrea Paul | F | 43 | - | |
Kyle Chiang | M | 44 | 5 Jahre | |
Themasap Khan | M | - |
Stanford University School of Medicine
| 5 Jahre |
Daniel O’Connell | M | 44 | 3 Jahre | |
Adi Barzel | M | - | 4 Jahre | |
Brian Luque | M | - | - | |
Mark Chao | M | - |
Stanford University School of Medicine
| 7 Jahre |
Sofia Ioannidou | M | 45 | 2 Jahre | |
Erez Chimovits | M | 60 | 4 Jahre | |
Leon E. Chen | M | 49 | 6 Jahre | |
Tomer Kariv | M | 62 | 3 Jahre | |
Mark Enyedy | M | 60 | 2 Jahre | |
J. Goater | M | 48 | 2 Jahre | |
Daphne Karydas | F | 49 | 2 Jahre | |
Matthias B. Jaffé | M | 50 | 3 Jahre | |
Joshua Blacher | M | 52 | - | |
Kevin Li | M | - |
Stanford University School of Medicine
| 4 Jahre |
Paul Herzich | M | 46 | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 95 | 95,00% |
Kanada | 5 | 5,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Mark A. Kay
- Persönliches Netzwerk